ND researchers have found that a new dual-action antibiotic—a compound of a class that treats #MRSA—kills #Cdiff bacteria and prevents germination of its spores.It could break C. diff's potentially life-threatening cycle of reinfection: https://t.co/20YxBJEZEa https://t.co/iPHuzDv80M